Status:
COMPLETED
Hypoperfusion-hypodensity Mismatch for the Identification of Patients With Stroke Within 4.5 Hours
Lead Sponsor:
University Hospital Muenster
Conditions:
Acute Ischemic Stroke
Eligibility:
All Genders
18+ years
Brief Summary
Intravenous thrombolysis is recommended within 4.5 hours of stroke onset. The aim of the study is to evaluate whether a hypodensity on native CT within the virtually entire area of hypoperfusion on pe...
Eligibility Criteria
Inclusion
- acute ischemic stroke
- evidence of acute intracranial vessel occlusion (any supratentorial proximal or peripheral artery of the anterior cerebral artery, middle cerebral artery or posterior cerebral artery territory) by CT hyper dense thrombus and/or CTangiography vessel occlusion and/or by ischemic perfusion deficit
- evidence for acute ischemic perfusion deficit, i.e. acute symptoms attributable to ischemic CT perfusion lesion
- complete native CT and CTperfusion performed on admission
- sufficient CT and CTperfusion quality for judgement of acute ischemic hypodensity
- known time of symptom onset.
Exclusion
- None
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
689 Patients enrolled
Trial Details
Trial ID
NCT04277728
Start Date
January 1 2018
End Date
December 31 2019
Last Update
February 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Münster
Münster, Germany